Singapore markets close in 7 hours 49 minutes

Novartis AG (NVSEF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
77.40-3.60 (-4.44%)
At close: 10:20AM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
52,788,000
52,877,000
49,898,000
48,677,000
53,166,000
Cost of revenue
15,521,000
15,867,000
15,121,000
14,425,000
18,407,000
Gross profit
37,267,000
37,010,000
34,777,000
34,252,000
34,759,000
Operating expenses
Research development
9,607,000
9,540,000
8,980,000
9,402,000
9,074,000
Selling general and administrative
14,696,000
14,886,000
14,197,000
14,369,000
16,471,000
Total operating expenses
26,392,000
25,321,000
24,625,000
25,166,000
26,590,000
Operating income or loss
10,875,000
11,689,000
10,152,000
9,086,000
8,169,000
Interest expense
811,000
811,000
869,000
850,000
957,000
Total other income/expenses net
14,842,000
15,339,000
673,000
499,000
6,372,000
Income before tax
24,892,000
26,137,000
9,878,000
8,940,000
13,835,000
Income tax expense
1,914,000
2,119,000
1,807,000
1,793,000
1,221,000
Income from continuing operations
22,978,000
24,018,000
8,071,000
7,147,000
12,614,000
Net income
22,982,000
24,021,000
8,072,000
11,732,000
12,611,000
Net income available to common shareholders
22,982,000
24,021,000
8,072,000
11,732,000
12,611,000
Basic EPS
-
10.71
3.55
5.12
5.44
Diluted EPS
-
10.63
3.52
5.06
5.38
Basic average shares
-
2,243,000
2,277,000
2,291,000
2,319,000
Diluted average shares
-
2,260,000
2,296,000
2,319,000
2,344,000
EBITDA
-
33,061,000
17,211,000
15,616,000
21,684,000